Erythema Multiforme Caused by the H<sub>2</sub>‐Blocker, Roxatidine

Horiuchi, Yasuhiro

doi:10.1111/j.1346-8138.2000.tb02182.x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2004

2024

Publication Types

Select...

Other4

Article1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Histamine H2‐receptor antagonists have been used widely for gastric or duodenal ulcers and hypersecretory syndromes with infrequent side effects. However, serious side effects of blood and skin, such as toxic epidermal necrolysis or erythema multiforme, have been reported to be induced by these drugs 2–4 . Recent reports suggest that some immunoregulatory T lymphocytes possess H2‐receptors.…”

mentioning

confidence: 99%

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

et al. 2005

View full text Add to dashboard Cite

mentioning

confidence: 99%

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

et al. 2005

View full text Add to dashboard Cite

Erythema Multiforme, Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis

Breathnach¹

2004

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

Reactive Inflammatory Erythemas

Rustin

Cerio

2016

Rook's Textbook of Dermatology, Ninth Edition

View full text Add to dashboard Cite

Multiple skin conditions can present with ring‐like or annular lesions for which a specific diagnosis can be made (e.g. tinea corporis, granuloma annulare, psoriasis or annular sarcoidosis). This chapter describes a group of conditions that do not necessarily lead to a specific underlying diagnosis and may pose diagnostic and therapeutic problems. It includes erythema multiforme, annular erythema of infancy, necrolytic migratory erythema (NME), erythema annulare centrifugum (EAC), erythema gyratum repens and erythema marginatum. EAC and subacute cutaneous lupus will be covered in separate chapters. Each eruption may have characteristic features and although diagnosis of erythema multiforme is often easy and there are a limited number of underlying causes, the diagnosis of NME may take time in view of the different manifestations of the disease. Physicians should be alert to the subtle eruption of erythema marginatum and the importance of diagnosing rheumatic fever. These cutaneous signs therefore present a challenge with heterogenous diseases presenting with varying morphologies.

show abstract

Erythema Multiforme Caused by the H₂‐Blocker, Roxatidine

Cited by 5 publications

References 5 publications

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

Erythema Multiforme, Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis

Reactive Inflammatory Erythemas

Contact Info

Product

Resources

About

Erythema Multiforme Caused by the H2‐Blocker, Roxatidine

Cited by 5 publications

References 5 publications

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

Erythrodermic drug eruption due to roxatidine acetate hydrochloride

Erythema Multiforme, Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis

Reactive Inflammatory Erythemas

Contact Info

Product

Resources

About

Erythema Multiforme Caused by the H₂‐Blocker, Roxatidine